Risk to bone health during treatment of endometriosis with dienogest
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Treatment for endometriosis with dienogest (DNG) associated with bone loss in 75%.
- Clinical significance is unclear.
Why this matters
- Endometriosis affects 10% of reproductive-aged women and is associated with pain and infertility.
- DNG is a synthetic nortestosterone derivati...